Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare Databases

Keyphrases

• Healthcare Database 100%
• Chimeric Antigen Receptor T Cells (CAR-T) 100%
• CAR T-cell Therapy 100%
• Population-based 33%
• Malignant Disease 33%
• Viral Infection 33%
• Source Population 33%
• Immune System 33%
• T Cells 33%
• Hematological Malignancies 33%
• Genetic Modification 33%
• Biopharmaceuticals 33%
• Solid Tumors 33%
• Loss-to-follow-up 33%
• Long Follow-up 33%
• Adoptive Cell Therapy 33%
• B-cell Malignancies 33%
• Viable Approach 33%
• Access to Data 33%
• Tumor Virus Infections 33%
• T-cell Monitoring 33%
• Authorization Data 33%
• Post-authorization 33%
• Advanced Products 33%
• Monitoring Project 33%

Medicine and Dentistry

• T Cell 100%
• Chimeric Antigen Receptor 100%
• CAR T-cell therapy 100%
• Disease 33%
• Cancer 33%
• Virus Infection 33%
• Immune System 33%
• B Cell 33%
• Hematologic Malignancy 33%
• Solid Malignant Neoplasm 33%
• Cell Therapy 33%
• Biopharmaceuticals 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chimeric Antigen Receptor 100%
• Disease 33%
• Virus Infection 33%
• Solid Malignant Neoplasm 33%
• Hematologic Malignancy 33%